These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6433234)

  • 1. Preparation and stability of cardioplegic solutions at a USAF Medical Center.
    Corey JM
    Mil Med; 1984 Aug; 149(8):474-5. PubMed ID: 6433234
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrieval of crystalloid cardioplegic solutions.
    Eucher PM; Buche M; Broka S; Schoevaerdts JC
    Ann Thorac Surg; 1996 Feb; 61(2):746-7. PubMed ID: 8572811
    [No Abstract]   [Full Text] [Related]  

  • 3. [The system of administration of cardioplegic solutions].
    Iakimov VB; Buldakova TL; Levit AL
    Grud Serdechnososudistaia Khir; 1990; (6):58-9. PubMed ID: 2245066
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxicity of cardioplegic solutions: evaluation by tissue culture.
    Carpentier S; Murawsky M; Carpentier A
    Circulation; 1981 Aug; 64(2 Pt 2):II90-5. PubMed ID: 7249335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages of blood cardioplegic solutions.
    Rosenkranz ER; Buckberg GD
    Ann Chir Gynaecol; 1987; 76(1):30-8. PubMed ID: 3296931
    [No Abstract]   [Full Text] [Related]  

  • 6. Supraphysiological levels of magnesium in cardioplegic arrest solutions: is there cause for concern?
    Tyers GF
    Can J Cardiol; 1995 Jan; 11(1):21-2. PubMed ID: 7850660
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aortic valve replacement in cardioplegic heart arrest].
    Stenzl W; Kraft-Kinz J; Rigler B; Tscheliessnigg KH; Hermann W; Dacar D; Metzler H; Rebak P
    Wien Med Wochenschr; 1983 May; 133(10):253-6. PubMed ID: 6880212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of viscosity on poststenotic distribution of cardioplegic solutions.
    Landymore RW; Kinley CE
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):944-6. PubMed ID: 6610080
    [No Abstract]   [Full Text] [Related]  

  • 9. [The optimal potassium concentration in cardioplegic solutions].
    Kito Y; Fujita T; Kosakai Y; Fujii H; Manabe H
    Nihon Kyobu Geka Gakkai Zasshi; 1985 Feb; 33(2):224-8. PubMed ID: 3998543
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardioplegic arrest in pigs. Effects of glucose-containing solutions.
    Salerno TA; Chiong MA
    J Thorac Cardiovasc Surg; 1980 Dec; 80(6):929-33. PubMed ID: 7431990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of cardioplegic solutions.
    Armistead S; Collins GE; Bowman JD; Digerness SB; Conti VR
    Am J Hosp Pharm; 1979 Oct; 36(10):1361-5. PubMed ID: 41451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized comparison of cardioplegic methods in the isolated paracorporeal dog heart.
    Warnecke H; Hetzer R; Franz P; Borst HG
    Thorac Cardiovasc Surg; 1980 Oct; 28(5):322-8. PubMed ID: 6161430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-ischemic protection of the myocardium by cardioplegic solutions].
    Onishchenko NA; Lubiako AA
    Vestn Akad Med Nauk SSSR; 1985; (4):40-7. PubMed ID: 4013508
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of crystalloid and blood cardioplegic solutions on myocardial cooling during myocardial revascularization.
    Landymore RW; Kinley CE
    Can J Surg; 1984 May; 27(3):257-9. PubMed ID: 6609757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphofunctional characteristics of the heart during preservation using a cardioplegic solution].
    Barinov EF; Kimbarovskaia EM; Evseeva LI; Dubovoĭ VA; El'bert ME
    Grudn Khir; 1983; (3):38-42. PubMed ID: 6345276
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of potassium-based cardioplegic solutions and pharmacologic agents on normothermic ischemic myocardium (author's transl)].
    Shida H
    Nihon Kyobu Geka Gakkai Zasshi; 1980 Jul; 28(7):1115-22. PubMed ID: 7462740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protection of the myocardium during open heart surgery with cold cardioplegic solutions].
    Marenović T; Jablanov J; Radojević D; Dragosavac D
    Vojnosanit Pregl; 1985; 42(5):360-2. PubMed ID: 4095932
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of temperature of cardioplegic solution.
    Behrendt DM; Jochim KE
    J Thorac Cardiovasc Surg; 1978 Sep; 76(3):353-7. PubMed ID: 682667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of halothane on post-cardioplegic functional recovery--the role of cardioplegic solution.
    Genade S; Tromp E; Lochner RC; Lochner A
    S Afr Med J; 1998 Apr; 88 Suppl 2():C96-8. PubMed ID: 9595004
    [No Abstract]   [Full Text] [Related]  

  • 20. Multi dose cardioplegic perfusion: a tool for long term heart arrest.
    Döring V; Bleese N; Rodewald G
    Angiology; 1984 May; 35(5):282-9. PubMed ID: 6721251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.